|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 360.55 USD | +0.62% |
|
+4.59% | +10.16% |
| 01:59am | An exuberant quarter for equities, but not an irrational one? |  |
| Jun. 29 | Medical journal retracts paper on Amgen's Tavneos drug trial after FDA findings | RE |
| Market Cap | 195B 170B 157B 147B 277B 18,398B 283B 1,893B 731B 9,076B 731B 715B 31,511B | P/E 2026 * |
23.5x | P/E 2027 * | 21.6x |
|---|---|---|---|---|---|
| Enterprise Value | 236B 207B 191B 178B 336B 22,340B 343B 2,299B 887B 11,021B 887B 868B 38,265B | EV / Sales 2026 * |
6.26x | EV / Sales 2027 * | 5.96x |
| Free-Float |
99.78% | Yield 2026 * |
2.8% | Yield 2027 * | 2.96% |
Last Transcript: Amgen Inc.
| 1 day | +0.04% | ||
| 1 week | +4.59% | ||
| Current month | +7.05% | ||
| 1 month | +7.05% | ||
| 3 months | +3.38% | ||
| 6 months | +9.38% | ||
| Current year | +10.16% |
| 1 week | 346 |  | 363.11 |
| 1 month | 322.3 | | 363.11 |
| Current year | 318.21 | | 391.29 |
| 1 year | 269.77 | | 391.29 |
| 3 years | 218.44 | | 391.29 |
| 5 years | 198.64 | | 391.29 |
| 10 years | 133.64 | | 391.29 |
| Manager | Title | Age | Since |
|---|---|---|---|
Robert Bradway
CEO | Chief Executive Officer | 63 | 2012-04-30 |
Peter Griffith
DFI | Director of Finance/CFO | 67 | 2019-12-31 |
Esteban Santos
COO | Chief Operating Officer | 59 | 2016-07-24 |
| Director | Title | Age | Since |
|---|---|---|---|
Robert Bradway
CHM | Chairman | 63 | 2012-12-31 |
Tyler Jacks
BRD | Director/Board Member | 65 | 2011-12-31 |
Robert Eckert
BRD | Director/Board Member | 71 | 2011-12-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| May. 18 | Free | Director | 665 | 0.0001% | ||
| May. 18 | Free | Director | 665 | 0.0001% | ||
| May. 18 | Free | Director | 665 | 0.0001% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.62% | +4.59% | +30.10% | +63.03% | 195B | |
| +1.81% | +11.60% | +58.61% | +164.79% | 1,097B | |
| +1.51% | +11.77% | +69.61% | +57.53% | 622B | |
| +0.38% | +10.56% | +39.49% | +90.88% | 449B | |
| -0.40% | +6.34% | +29.51% | +24.01% | 334B | |
| +1.43% | +6.70% | +43.28% | +28.59% | 294B | |
| +1.22% | +3.55% | +32.89% | +42.00% | 286B | |
| +1.18% | +3.61% | -27.47% | -42.00% | 213B | |
| -1.21% | +1.17% | +14.15% | +66.20% | 157B | |
| +0.33% | -2.83% | +0.74% | -32.53% | 139B | |
| Average | +0.22% | +5.74% | +29.09% | +46.25% | 378.56B | |
| Weighted average by Cap. | +0.11% | +8.26% | +42.17% | +77.92% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 37.76B 33.06B 30.52B 28.5B 53.66B 3,570B 54.88B 367B 142B 1,761B 142B 139B 6,115B | 38.71B 33.9B 31.29B 29.22B 55.01B 3,660B 56.26B 377B 145B 1,806B 145B 142B 6,269B |
| Net income | 8.23B 7.21B 6.65B 6.21B 11.7B 778B 11.96B 80.07B 30.91B 384B 30.91B 30.23B 1,333B | 8.86B 7.76B 7.17B 6.69B 12.6B 838B 12.88B 86.23B 33.29B 413B 33.29B 32.56B 1,436B |
| Net Debt | 41.7B 36.52B 33.71B 31.48B 59.26B 3,943B 60.61B 406B 157B 1,945B 157B 153B 6,753B | 36.06B 31.57B 29.15B 27.22B 51.24B 3,409B 52.4B 351B 135B 1,682B 135B 132B 5,839B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-06-29 | $360.55 | +0.62% | 2,461,887 |
| 26-06-26 | $358.33 | +1.56% | 3,610,561 |
| 26-06-25 | $352.82 | +0.40% | 2,341,847 |
| 26-06-24 | $351.43 | +1.27% | 2,391,890 |
| 26-06-23 | $347.01 | +0.66% | 2,304,951 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- AMGN Stock
Select your edition
All financial news and data tailored to specific country editions
